Imaging, Digital, Angiography Symposium 1

Related

• 

  Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

  Andrew J. Barkmeier, MD

  Annual Meeting Talks

  2024

• 

  Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)

  Victor Hugo Gonzalez, MD

  Annual Meeting Talks

  2024

• 

  Three-Year Outcomes of the PALADIN Phase IV Study: Comparison of Anatomical Metrics, Efficacy, and Treatment Burden Post FAc

  Christopher D. Riemann, MD

  Annual Meeting Talks

  2022